Status:
COMPLETED
Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA) Prone vs Supine in Premature Infants
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Neonatal Oxygen Desaturation
Premature
Eligibility:
All Genders
1-3 years
Phase:
NA
Brief Summary
This research study is being done to investigate the effect of changing an infant's body position on how hard the baby works to breathe, the baby's oxygen level, the baby's carbon dioxide level, the b...
Eligibility Criteria
Inclusion
- Viable infants born at ≤32 weeks of gestation on non-invasive NAVA.
- Infant must be stable on NAVA for at least 24 hours prior to the study
Exclusion
- Infants with congenital heart disease (CHD)
- Infants with persistent pulmonary hypertension (PPHN)
- Infants with contraindications to using NAVA (e.g. neuromuscular blockage or paralysis, absent electrical signal from the diaphragm, esophageal tears or bleeding, cardiac pacemakers) or infants in whom an NG/OG catheter cannot be placed.
Key Trial Info
Start Date :
September 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05968586
Start Date
September 11 2023
End Date
December 31 2024
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Health Milton S Hershey Medical Center
Hershey, Pennsylvania, United States, 17033